Clinical Characteristics of COVID-19 Patients and Application to an Artificial Intelligence System for Disease Surveillance.
Ying-Chuan WangDung-Jang TsaiLi-Chen YenYa-Hsin YaoTsung-Ta ChiangChun-Hsiang ChiuTe-Yu LinKuo-Ming YehFeng-Yee ChangPublished in: Journal of clinical medicine (2022)
During the coronavirus disease (COVID-19) pandemic, we admitted suspected or confirmed COVID-19 patients to our isolation wards between 2 March 2020 and 4 May 2020, following a well-designed and efficient assessment protocol. We included 217 patients suspected of COVID-19, of which 27 had confirmed COVID-19. The clinical characteristics of these patients were used to train artificial intelligence (AI) models such as support vector machine (SVM), decision tree, random forest, and artificial neural network for diagnosing COVID-19. When analyzing the performance of the models, SVM showed the highest sensitivity (SVM vs. decision tree vs. random forest vs. artificial neural network: 100% vs. 42.86% vs. 28.57% vs. 71.43%), while decision tree and random forest had the highest specificity (SVM vs. decision tree vs. random forest vs. artificial neural network: 88.37% vs. 100% vs. 100% vs. 94.74%) in the diagnosis of COVID-19. With the aid of AI models, physicians may identify COVID-19 patients earlier, even with few baseline data available, and segregate infected patients earlier to avoid hospital cluster infections and to ensure the safety of medical professionals and ordinary patients in the hospital.
Keyphrases
- artificial intelligence
- neural network
- coronavirus disease
- sars cov
- end stage renal disease
- machine learning
- big data
- climate change
- chronic kidney disease
- ejection fraction
- deep learning
- newly diagnosed
- healthcare
- randomized controlled trial
- emergency department
- peritoneal dialysis
- primary care
- decision making
- respiratory syndrome coronavirus
- pulmonary embolism
- mass spectrometry
- adverse drug
- data analysis